LLY · 8-K · 20260805PR000077

Operating Expense Trends - R&D

ELI LILLY & Co · 2026-08-05 · Importance 47 · Surprise 22

Research and development expense increased 14% year over year to $3.819 billion in Q2 2026.,R&D expense represented 17% of Q2 revenue, compared with approximately 21% in Q2 2025 based on reported revenue and expense.,The increase was driven by continued investment in Lilly’s early- and late-stage portfolio.,Six-month R&D expense increased 21% to $7.329 billion from $6.070 billion.

Key facts

• Q2 2026 research and development expenses increased 14% to $3,819 million, or 17% of revenue. source